Nephros Inc

Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment consists of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate, and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Nephros Inc reports first profitable quarter, eyes growth opportunities

Nephros Inc delivered a strong performance in Q3 2024, achieving profitability and operational efficiency gains.
While facing revenue challenges and liquidity concerns, the company's strategic initiatives and focus on financial discipline position it for growth.
Opportunities in new markets and customer engagement through digital tools provide avenues for future expansion.
Balancing growth pursuits with financial prudence will be crucial for Nephros Inc's sustained success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

SOUTH ORANGE, NJ, Feb. 22, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc.  (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced it will file its fourth quarter and fiscal 2022 results on Wednesday, March 8, 2023 after market close and will host a conference call that same day at 4:30pm ET.

Nephros Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call

Fourth Quarter Net Revenue of $2.6 Million; Full-Year Net Revenue of $10.0 Million; Active Customer Sites Continue to Climb

Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2022

Nephros, Inc. (NASDAQ:NEPH ) Q3 2022 Earnings Conference Call November 2, 2022 4:30 PM ET Company Participants Kirin Smith - PCG Advisory Andrew Astor - President and CEO Conference Call Participants Marc Wiesenberger - B. Riley Securities Paul Resnik - Resnik Asset Management Operator Good day, everyone, and welcome to the Nephros, Inc. Third Quarter 2022 Financial Results Conference Call.

Nephros, Inc. (NEPH) Q3 2022 Earnings Call Transcript

Nephros Inc. (NEPH) delivered earnings and revenue surprises of 0% and 4.82%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Nephros Inc. (NEPH) Reports Q3 Loss, Misses Revenue Estimates

Third-Quarter Net Revenue of $2.4 Million;

Nephros Announces Results for Quarter Ended September 30, 2022

Nephros Inc. (NEPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will Nephros Inc. (NEPH) Report Negative Earnings Next Week? What You Should Know

SOUTH ORANGE, NJ, Oct. 19, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its third-quarter financial results on Wednesday, November 2, 2022 after market close and will host a conference call that same day at 4:30 pm ET.

Nephros Third Quarter 2022 Financial Results Conference Call

South Orange, New Jersey--(Newsfile Corp. - October 12, 2022) - Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing innovative filtration and pathogen detection solutions to healthcare and commercial markets, today announced that Andy Astor, Chief Executive Officer of Nephros has been selected to present at the LD Micro Main Event XV on Tuesday October 25, 2022 at 9:30am PT at the Luxe Sunset Boulevard Hotel in Los Angeles.

Nephros to Present at LD Micro Main Event XV

Sale Reduces Cash Burn, Includes Seven-Year Earn-Out Provision; Third Quarter Revenue Expected to be Approximately $2.5 Million; Active Customer Sites Increase 18% YoY

Nephros Announces Agreement to Sell Pathogen Detection Systems Business and Preliminary Results for Quarter Ended September 30, 2022

SOUTH ORANGE, NJ, Sept. 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced it has shipped 3,000 commercial water filters as part of its ongoing annual contract with Donastar Enterprises LLC and Tractor Beverage Co. in service of a national chain of fast-casual restaurants.

Nephros Partners with Donastar and Tractor Beverage Company to Supply and Service Nationwide Fast-Casual Restaurant Operation

SOUTH ORANGE, NJ, Sept. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced the appointment of Joe Harris to its Board of Directors.

Nephros Appoints Joe Harris to Its Board of Directors

Nephros, Inc. (NASDAQ:NEPH ) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET Company Participants Stephanie Prince - PCG Advisory, IR Andy Astor - President and CEO Conference Call Participants Marc Wiesenberger - B. Riley FBR Ralph Weil - R.

Nephros, Inc.'s (NEPH) CEO Andy Astor on Q2 2022 Results - Earnings Call Transcript

Nephros Inc. (NEPH) delivered earnings and revenue surprises of 14.29% and 6.82%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Nephros Inc. (NEPH) Reports Q2 Loss, Tops Revenue Estimates

Second Quarter Net Revenue of $2.9 Million, a 27% Year-Over-Year Increase; Active Customer Sites Climb 21% to New Record

Nephros Announces Results for Quarter Ended June 30, 2022

SOUTH ORANGE, NJ, July 27, 2022 (GLOBE NEWSWIRE) -- via  NewMediaWire --   Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it will file its second-quarter financial results on Wednesday, August 10, 2022 after market close and will host a conference call that same day at 4:30 PM ET.

Nephros Second Quarter 2022 Financial Results Conference Call

Second Quarter Revenue of $2.9 Million, Year-Over-Year Increase of 27%; Number of Active Customer Sites Climbs 21% Year-Over-Year

Nephros Announces Preliminary Results for Quarter Ended June 30, 2022 and Projects Positive Net Cash Flow in 12 Months

The First and Only FDA-Cleared Device Available in the United States to Provide Hemodiafiltration Therapy to Dialysis Patients

Nephros Receives FDA 510(k) Clearance for HDF Assist Module

Nephros, Inc. (NASDAQ:NEPH ) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Kirin Smith - President, PCG Advisory Andy Astor - President and Chief Executive Officer Wes Lobo - Chief Commercial Officer Conference Call Participants Anthony Vendetti - Maxim Group Sahil Kazmi - B. Riley Securities Operator Good day and welcome to the Nephros, Inc. First Quarter 2022 Financial Results Conference Call.

Nephros, Inc. (NEPH) CEO Andy Astor on Q1 2022 Results - Earnings Call Transcript

Nephros Inc. (NEPH) delivered earnings and revenue surprises of -53.85% and 25.10%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Nephros Inc. (NEPH) Reports Q1 Loss, Misses Revenue Estimates

First Quarter Net Revenue of $2.2 Million; Active Customer Sites Climb 17% to New Record

Nephros Announces Results for Quarter Ended March 31, 2022

SOUTH ORANGE, NJ, April 27, 2022 (GLOBE NEWSWIRE) -- via  NewMediaWire -- Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it will file its first-quarter financial results on Wednesday, May 4, 2022 after market close and will host a conference call that same day at 4:30 PM ET.

Nephros First Quarter 2022 Financial Results Conference Call

Rebrand reflects an integrated approach to water safety, with expanded focus on customer solutions and educational resources

Nephros Unveils New Branding and Website

SOUTH ORANGE, NJ, March 21, 2022 (GLOBE NEWSWIRE) -- via  NewMediaWire --  Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing innovative filtration and pathogen detection solutions to healthcare and commercial markets, today announced that Andy Astor, Chief Executive Officer of Nephros, will be presenting at the 2022 Virtual Growth Conference. During this event, Mr. Astor will provide an overview of how Nephros is advancing water safety through pathogen detection and water purification.

Nephros to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest

Nephros, Inc. (NEPH) CEO Andy Astor on Q4 2021 Results - Earnings Call Transcript

Nephros Inc. (NEPH) delivered earnings and revenue surprises of -10% and 1.53%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

News for Nephros Inc Stock (NEPH)